0000899243-21-009380.txt : 20210303
0000899243-21-009380.hdr.sgml : 20210303
20210303161540
ACCESSION NUMBER: 0000899243-21-009380
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gall Matthew
CENTRAL INDEX KEY: 0001816194
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39401
FILM NUMBER: 21709145
MAIL ADDRESS:
STREET 1: C/O ITEOS THERAPEUTICS, INC.
STREET 2: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iTeos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001808865
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-204-4583
MAIL ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-01
0
0001808865
iTeos Therapeutics, Inc.
ITOS
0001816194
Gall Matthew
C/O ITEOS THERAPEUTICS, INC.
139 MAIN STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
41.58
2021-03-01
4
A
0
72000
0.00
A
2031-03-01
Common Stock
72000
72000
D
This stock option shall vest over 4 years, with 25% vesting on March 1, 2022 and thereafter in equal monthly installments over the next 36 months subject to the Reporting Person's continued service to the Issuer.
/s/ Michel Detheux, as Attorney-in-Fact
2021-03-03